DAB Substrate Kit Suppressing Aggregation via Surfactant

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Diaminobenzidine (DAB) aggregation in chromogenic reaction solutions leads to precipitation and nonspecific staining in immunostaining and in situ hybridization, reducing the intensity of specific staining and storage stability of DAB-containing substrate kits.

Innovation Solution

A DAB-containing substrate kit is developed with a two- or three-component system, incorporating tetraethylenediaminetetraacetic acid disodium salt dihydrate (EDTA-2Na) as a chelating agent and polyoxyethylene (23) lauryl ether nonionic surfactant (Brij 35), along with imidazole and hydrogen peroxide, to suppress DAB aggregation and enhance specific staining intensity while reducing background staining.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Power

If imidazole is used as a sensitizer to accelerate DAB reaction, then the staining intensity is improved, but DAB aggregation occurs causing precipitation and nonspecific background staining

Engineering Contradiction:
Improvestaining intensityVSAvoidDAB aggregation and precipitation
Core Design Contradiction:
PowerVSObject-generated harmful factors

Solution Approach 1:

The patent introduces a nonionic surfactant as an intermediary substance that mediates between DAB and imidazole. The surfactant's hydrophobic interaction with DAB and hydrophilic interaction with water prevents DAB aggregation while allowing imidazole to maintain its sensitizing function, thus resolving the contradiction between staining intensity and precipitation

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent creates a composite chromogenic system combining DAB, imidazole, and nonionic surfactant in specific proportions. This composite formulation allows the components to work synergistically: imidazole accelerates the reaction for intense staining while the surfactant prevents aggregation, achieving both high staining intensity and solution stability

Inventive Principle:
Principle #40Composite materials

2Ease of operation

If DAB-containing substrate solution is stored for extended periods, then convenience of use is improved, but DAB aggregation and precipitation occur reducing storage stability

Engineering Contradiction:
Improvestorage convenienceVSAvoidstorage stability
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent applies preliminary action by incorporating the nonionic surfactant into the DAB substrate solution before storage. This preemptive measure prevents DAB aggregation from occurring during storage, maintaining solution stability over extended periods while providing the convenience of pre-prepared substrates

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The nonionic surfactant acts as a protective intermediary that stabilizes DAB molecules during storage. It forms a protective environment around DAB, preventing aggregation and precipitation, thereby extending the storage life of the substrate solution without compromising reliability

Inventive Principle:
Principle #24Intermediary (Mediator)

3Measurement precision

If high concentration of imidazole is used to enhance specific staining, then sensitivity is improved, but nonspecific background staining increases

Engineering Contradiction:
Improvestaining sensitivityVSAvoidbackground staining
Core Design Contradiction:
Measurement precisionVSObject-generated harmful factors

Solution Approach 1:

The nonionic surfactant serves as a selective intermediary that enhances the interaction between DAB and peroxidase while suppressing non-specific interactions. It maintains high staining sensitivity through imidazole while preventing background staining by stabilizing DAB and reducing its non-specific binding to tissues

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The kit effectively suppresses DAB aggregation, maintains staining intensity comparable to freshly prepared solutions for an extended period, and improves storage stability, reducing background staining and precipitation, thus enhancing the usability and effectiveness of the substrate kit in immunohistochemical and immunocytochemical staining.

Implementation Method 1

incorporating tetraethylenediaminetetraacetic acid disodium salt dihydrate (EDTA-2Na) as a chelating agent

Methodology Applied
Scientific EffectChelation:

Implementation Method 2

polyoxyethylene (23) lauryl ether nonionic surfactant (Brij 35)

Methodology Applied
Scientific EffectSurfactant action: Surfactant

Implementation Method 3

peroxidase, which is mostly plant-derived horseradish peroxidase (HRP)

Methodology Applied
Scientific EffectEnzymatic catalysis: Enzyme

Implementation Method 4

Hydrogen donor for the enzymatic reaction of HRP... hydrogen peroxide

Methodology Applied
Scientific EffectOxidation: Oxidation

Implementation Method 5

imidazole is effective in accelerating DAB reaction

Methodology Applied
Scientific EffectCatalysis: Catalysis

Data Source

PatentEP2963123B1DAB-containing substrate kit for dyeing use which is produced using labelling enzyme
Publication Date: 2020.04.08 NICHIREI BIOSCIENCE INC

AI summary

Provided is a DAB-containing substrate kit that is capable of enhancing specific staining intensity and reducing precipitation due to DAB aggregation in DAB-containing substrate solution and nonspecific staining, such as background staining, in chromogenic reaction using a peroxidase-labeled antibody, by the use of chromogenic reaction solution containing DAB and its sensitizer imidazole. The kit includes chromophore-containing solution (A) containing a peroxidase chromophore DAB and water; and chromogenic reagent (B) containing: at least one chelating agent selected from the group consisting of EDTA-2Na, EDTA-2NH4, GEDTA, and NTA; POE and/or POP alkyl ether nonionic surfactant; imidazole; hydrogen peroxide; and water. The kit is in a system of two- or more components with at least the chromophore-containing solution (A) and the chromogenic reagent (B) being separately stored.